Results 241 to 250 of about 466,856 (291)
Some of the next articles are maybe not open access.
Outpatient Psychiatric Medications and Glaucoma
Psychosomatics, 1976and anti parkinsonian drugs.3.16.17.22.23 The so-called "minor tranquilizers" (benzodiazepines, hydroxyzine etc) have not been implicated in increased lOP. A review of the revelant literature reveals little prac tical cause for alarm2.6,14.18.24-33 and most studies agree that even in older patients with active closed- or open angle glaucoma ...
W H, Reid, P, Blouin
openaire +2 more sources
A Review of Psychotropic Medications and the Glaucomas
International Pharmacopsychiatry, 2017Four general groups of psychotropic drugs are examined with respect to possible adverse effects upon intraocular pressure. After a brief discussion of the various mechanisms of the glaucomas, both general and specific information is provided and discussed concerning antipsychotic, antidepressant, antiparkinsonian and antianxiety preparations of a ...
W H, Reid, P, Blouin, M, Schermer
openaire +2 more sources
Ophthalmology Clinics of North America, 2005
Prescribing medical treatment for glaucoma requires a complex decision-making process that involves the patient, the severity of the disease, the therapeutic options available, and their potential side effects. Lowering intraocular pressure, a known risk factor for progression, has been the mainstay of glaucoma treatment.
openaire +2 more sources
Prescribing medical treatment for glaucoma requires a complex decision-making process that involves the patient, the severity of the disease, the therapeutic options available, and their potential side effects. Lowering intraocular pressure, a known risk factor for progression, has been the mainstay of glaucoma treatment.
openaire +2 more sources
Maximal Medical Therapy for Glaucoma
Archives of Ophthalmology, 1997Not too LONG AGO, maximal tolerated medical therapy (MTMT) for glaucoma usually meant a β-blocker, a cholinergic agent (usually pilocarpine or carbachol), and an oral carbonic anhydrase inhibitor (CAI) (usually diamox or neptazane). Sometimes epinephrine or dipivefrin was added to the regimen.
T J, Zimmerman, R D, Fechtner
openaire +2 more sources
Pediatric Glaucoma: Glaucoma Medications and Steroids
2009The majority of medications used for IOP-lowering in adults are not licensed for use in children. Package inserts on topical medications warn that “safety and efficacy has not been established in children.” Despite this fact, most topical drops are used in children and are safe.
JoAnn A. Giaconi +2 more
openaire +1 more source
Cost Analysis of Glaucoma Medications
Journal of Glaucoma, 2000To evaluate the yearly cost in 1998 of glaucoma medications to patients and to the Health Plan at a university-affiliated teaching hospital with its own health maintenance organization.Data concerning Health Plan glaucoma-medication prescriptions for 1998 were retrieved from the hospital pharmacy database.The most costly medication per patient per year
S D, Vold, D A, Wiggins, J, Jackimiec
openaire +2 more sources
Glaucoma and cardioprotective medication
Acta Ophthalmologica, 2022AbstractPurpose: To investigate the impact of cholesterol‐lowering medication, anticoagulants, and antihypertensive medication on the onset of glaucoma in Denmark from 1996 to 2018.Methods: We included all 2.5 million Danish individuals over 40 years of age.
Anna Horwitz +6 more
openaire +1 more source
Drugs & Aging, 2006
As with many diseases, glaucoma increases in frequency in older populations, and is very often encountered in patients taking multiple medications. While the exact mechanism of glaucomatous optic neuropathy (GON) is not known, intraocular pressure (IOP) is thought to be central to the process, and reducing IOP is the only known effective treatment. The
Elliott, Kanner, James C, Tsai
openaire +2 more sources
As with many diseases, glaucoma increases in frequency in older populations, and is very often encountered in patients taking multiple medications. While the exact mechanism of glaucomatous optic neuropathy (GON) is not known, intraocular pressure (IOP) is thought to be central to the process, and reducing IOP is the only known effective treatment. The
Elliott, Kanner, James C, Tsai
openaire +2 more sources
Advances in medical therapy for glaucoma
Current Opinion in Ophthalmology, 2020Purpose of review To discuss a new class of medication that has recently become available for the treatment of glaucoma; as well as share insights into developments in glaucoma medicine administration which has the potential to revolutionize medical therapy for glaucoma.
Erik, Ostler +3 more
openaire +2 more sources
Iatrogenic Glaucoma Secondary to Medications
The American Journal of Medicine, 2011Glaucoma is a progressive optic neuropathy with primary and secondary forms. Iatrogenic glaucoma secondary to medications is potentially blinding but preventable. Most drug profiles listing glaucoma as a contraindication or an adverse effect are concerned with inducing acute angle-closure glaucoma.
M Reza, Razeghinejad +2 more
openaire +2 more sources